Matthew M Y Lee, Nazim Ghouri, Darren K McGuire, Martin K Rutter, Naveed Sattar. Diabetes Care 2021
Times Cited: 10
Times Cited: 10
Times Cited
Times Co-cited
Similarity
Impending epidemic: future projection of heart failure in Japan to the year 2055.
Yuji Okura, Mahmoud M Ramadan, Yukiko Ohno, Wataru Mitsuma, Komei Tanaka, Masahiro Ito, Keisuke Suzuki, Naohito Tanabe, Makoto Kodama, Yoshifusa Aizawa. Circ J 2008
Yuji Okura, Mahmoud M Ramadan, Yukiko Ohno, Wataru Mitsuma, Komei Tanaka, Masahiro Ito, Keisuke Suzuki, Naohito Tanabe, Makoto Kodama, Yoshifusa Aizawa. Circ J 2008
10
The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.
Qian Zhang, Challa Tenagne Delessa, Robert Augustin, Mostafa Bakhti, Gustav Colldén, Daniel J Drucker, Annette Feuchtinger, Cristina Garcia Caceres, Gerald Grandl, Alexandra Harger,[...]. Cell Metab 2021
Qian Zhang, Challa Tenagne Delessa, Robert Augustin, Mostafa Bakhti, Gustav Colldén, Daniel J Drucker, Annette Feuchtinger, Cristina Garcia Caceres, Gerald Grandl, Alexandra Harger,[...]. Cell Metab 2021
10
Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.
Chutima Talchai, Shouhong Xuan, Hua V Lin, Lori Sussel, Domenico Accili. Cell 2012
Chutima Talchai, Shouhong Xuan, Hua V Lin, Lori Sussel, Domenico Accili. Cell 2012
10
Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors.
G A Nichols, T A Hillier, J R Erbey, J B Brown. Diabetes Care 2001
G A Nichols, T A Hillier, J R Erbey, J B Brown. Diabetes Care 2001
10
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis.
Junnosuke Miura, Makoto Imori, Hiroshi Nishiyama, Takeshi Imaoka. Diabetes Ther 2020
Junnosuke Miura, Makoto Imori, Hiroshi Nishiyama, Takeshi Imaoka. Diabetes Ther 2020
33
Superior HbA1c control with the fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double-blind, randomized trial.
Hirotaka Watada, Shizuka Kaneko, Mitsuhisa Komatsu, Bue Ross Agner, Tomoyuki Nishida, Mattis Ranthe, Jiro Nakamura. Diabetes Obes Metab 2019
Hirotaka Watada, Shizuka Kaneko, Mitsuhisa Komatsu, Bue Ross Agner, Tomoyuki Nishida, Mattis Ranthe, Jiro Nakamura. Diabetes Obes Metab 2019
10
Gut hormone polyagonists for the treatment of type 2 diabetes.
Sara J Brandt, Anna Götz, Matthias H Tschöp, Timo D Müller. Peptides 2018
Sara J Brandt, Anna Götz, Matthias H Tschöp, Timo D Müller. Peptides 2018
10
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
Marcel H A Muskiet, Lennart Tonneijck, Mark M Smits, Michaël J B van Baar, Mark H H Kramer, Ewout J Hoorn, Jaap A Joles, Daniël H van Raalte. Nat Rev Nephrol 2017
Marcel H A Muskiet, Lennart Tonneijck, Mark M Smits, Michaël J B van Baar, Mark H H Kramer, Ewout J Hoorn, Jaap A Joles, Daniël H van Raalte. Nat Rev Nephrol 2017
10
Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes.
Sophie Hallakou-Bozec, Guillaume Vial, Micheline Kergoat, Pascale Fouqueray, Sébastien Bolze, Anne-Laure Borel, Eric Fontaine, David E Moller. Diabetes Obes Metab 2021
Sophie Hallakou-Bozec, Guillaume Vial, Micheline Kergoat, Pascale Fouqueray, Sébastien Bolze, Anne-Laure Borel, Eric Fontaine, David E Moller. Diabetes Obes Metab 2021
10
GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists.
Jens Juul Holst, Mette Marie Rosenkilde. J Clin Endocrinol Metab 2020
Jens Juul Holst, Mette Marie Rosenkilde. J Clin Endocrinol Metab 2020
10
Imeglimin normalizes glucose tolerance and insulin sensitivity and improves mitochondrial function in liver of a high-fat, high-sucrose diet mice model.
Guillaume Vial, Marie-Agnès Chauvin, Nadia Bendridi, Annie Durand, Emmanuelle Meugnier, Anne-Marie Madec, Nathalie Bernoud-Hubac, Jean-Paul Pais de Barros, Éric Fontaine, Cécile Acquaviva,[...]. Diabetes 2015
Guillaume Vial, Marie-Agnès Chauvin, Nadia Bendridi, Annie Durand, Emmanuelle Meugnier, Anne-Marie Madec, Nathalie Bernoud-Hubac, Jean-Paul Pais de Barros, Éric Fontaine, Cécile Acquaviva,[...]. Diabetes 2015
10
Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.
Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver,[...]. Sci Transl Med 2013
Brian Finan, Tao Ma, Nickki Ottaway, Timo D Müller, Kirk M Habegger, Kristy M Heppner, Henriette Kirchner, Jenna Holland, Jazzminn Hembree, Christine Raver,[...]. Sci Transl Med 2013
10
Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans.
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten E Stidsen, Trine Porsgaard, Christian Fledelius, Hanne H F Refsgaard, Sanne Gram-Nielsen,[...]. J Med Chem 2021
Thomas B Kjeldsen, František Hubálek, Claudia U Hjørringgaard, Tina M Tagmose, Erica Nishimura, Carsten E Stidsen, Trine Porsgaard, Christian Fledelius, Hanne H F Refsgaard, Sanne Gram-Nielsen,[...]. J Med Chem 2021
10
Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
10
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
Philip Ambery, Victoria E Parker, Michael Stumvoll, Maximilian G Posch, Tim Heise, Leona Plum-Moerschel, Lan-Feng Tsai, Darren Robertson, Meena Jain, Marcella Petrone,[...]. Lancet 2018
Philip Ambery, Victoria E Parker, Michael Stumvoll, Maximilian G Posch, Tim Heise, Leona Plum-Moerschel, Lan-Feng Tsai, Darren Robertson, Meena Jain, Marcella Petrone,[...]. Lancet 2018
10
The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.
Juan Pablo Frias, Edward J Bastyr, Louis Vignati, Matthias H Tschöp, Christophe Schmitt, Klara Owen, Rune Haubo Christensen, Richard D DiMarchi. Cell Metab 2017
Juan Pablo Frias, Edward J Bastyr, Louis Vignati, Matthias H Tschöp, Christophe Schmitt, Klara Owen, Rune Haubo Christensen, Richard D DiMarchi. Cell Metab 2017
10
Regulation of renal function by the gastrointestinal tract: potential role of gut-derived peptides and hormones.
A R Michell, E S Debnam, R J Unwin. Annu Rev Physiol 2008
A R Michell, E S Debnam, R J Unwin. Annu Rev Physiol 2008
10
Diabetes mellitus--advances and challenges in human β-cell proliferation.
Peng Wang, Nathalie M Fiaschi-Taesch, Rupangi C Vasavada, Donald K Scott, Adolfo García-Ocaña, Andrew F Stewart. Nat Rev Endocrinol 2015
Peng Wang, Nathalie M Fiaschi-Taesch, Rupangi C Vasavada, Donald K Scott, Adolfo García-Ocaña, Andrew F Stewart. Nat Rev Endocrinol 2015
10
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
Piotr A Mroz, Brian Finan, Vasily Gelfanov, Bin Yang, Matthias H Tschöp, Richard D DiMarchi, Diego Perez-Tilve. Mol Metab 2019
Piotr A Mroz, Brian Finan, Vasily Gelfanov, Bin Yang, Matthias H Tschöp, Richard D DiMarchi, Diego Perez-Tilve. Mol Metab 2019
10
Semaglutide lowers body weight in rodents via distributed neural pathways.
Sanaz Gabery, Casper G Salinas, Sarah J Paulsen, Jonas Ahnfelt-Rønne, Tomas Alanentalo, Arian F Baquero, Stephen T Buckley, Erzsébet Farkas, Csaba Fekete, Klaus S Frederiksen,[...]. JCI Insight 2020
Sanaz Gabery, Casper G Salinas, Sarah J Paulsen, Jonas Ahnfelt-Rønne, Tomas Alanentalo, Arian F Baquero, Stephen T Buckley, Erzsébet Farkas, Csaba Fekete, Klaus S Frederiksen,[...]. JCI Insight 2020
10
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-L randomized clinical trial.
Hideaki Kaneto, Akane Takami, Robert Spranger, Atsushi Amano, Daisuke Watanabe, Elisabeth Niemoeller. Diabetes Obes Metab 2020
Hideaki Kaneto, Akane Takami, Robert Spranger, Atsushi Amano, Daisuke Watanabe, Elisabeth Niemoeller. Diabetes Obes Metab 2020
10
Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
Elisa P Jensen, Steen S Poulsen, Hannelouise Kissow, Niels-Henrik Holstein-Rathlou, Carolyn F Deacon, Boye L Jensen, Jens J Holst, Charlotte M Sorensen. Am J Physiol Renal Physiol 2015
Elisa P Jensen, Steen S Poulsen, Hannelouise Kissow, Niels-Henrik Holstein-Rathlou, Carolyn F Deacon, Boye L Jensen, Jens J Holst, Charlotte M Sorensen. Am J Physiol Renal Physiol 2015
10
Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.
Mikkel Christensen, Louise Vedtofte, Jens J Holst, Tina Vilsbøll, Filip K Knop. Diabetes 2011
Mikkel Christensen, Louise Vedtofte, Jens J Holst, Tina Vilsbøll, Filip K Knop. Diabetes 2011
10
Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake.
Alice E Adriaenssens, Emma K Biggs, Tamana Darwish, John Tadross, Tanmay Sukthankar, Milind Girish, Joseph Polex-Wolf, Brain Y Lam, Ilona Zvetkova, Warren Pan,[...]. Cell Metab 2019
Alice E Adriaenssens, Emma K Biggs, Tamana Darwish, John Tadross, Tanmay Sukthankar, Milind Girish, Joseph Polex-Wolf, Brain Y Lam, Ilona Zvetkova, Warren Pan,[...]. Cell Metab 2019
10
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
Tamer Coskun, Kyle W Sloop, Corina Loghin, Jorge Alsina-Fernandez, Shweta Urva, Krister B Bokvist, Xuewei Cui, Daniel A Briere, Over Cabrera, William C Roell,[...]. Mol Metab 2018
Tamer Coskun, Kyle W Sloop, Corina Loghin, Jorge Alsina-Fernandez, Shweta Urva, Krister B Bokvist, Xuewei Cui, Daniel A Briere, Over Cabrera, William C Roell,[...]. Mol Metab 2018
10
Heart failure prevalence, incidence, and mortality in the elderly with diabetes.
Alain G Bertoni, W Gregory Hundley, Mark W Massing, Denise E Bonds, Gregory L Burke, David C Goff. Diabetes Care 2004
Alain G Bertoni, W Gregory Hundley, Mark W Massing, Denise E Bonds, Gregory L Burke, David C Goff. Diabetes Care 2004
10
Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems.
M Matsuhisa, T Morishima, I Nakahara, T Tomita, Y Shiba, M Kubota, M Wada, T Kanda, M Kubota, R Kawamori,[...]. Diabetes 1997
M Matsuhisa, T Morishima, I Nakahara, T Tomita, Y Shiba, M Kubota, M Wada, T Kanda, M Kubota, R Kawamori,[...]. Diabetes 1997
10
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.
Julio Rosenstock, Carol Wysham, Juan P Frías, Shizuka Kaneko, Clare J Lee, Laura Fernández Landó, Huzhang Mao, Xuewei Cui, Chrisanthi A Karanikas, Vivian T Thieu. Lancet 2021
Julio Rosenstock, Carol Wysham, Juan P Frías, Shizuka Kaneko, Clare J Lee, Laura Fernández Landó, Huzhang Mao, Xuewei Cui, Chrisanthi A Karanikas, Vivian T Thieu. Lancet 2021
10
Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
V A Gault, F P M O'Harte, P Harriott, M H Mooney, B D Green, P R Flatt. Diabetologia 2003
V A Gault, F P M O'Harte, P Harriott, M H Mooney, B D Green, P R Flatt. Diabetologia 2003
10
Stimulation of insulin secretion by gastric inhibitory polypeptide in man.
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
J Dupre, S A Ross, D Watson, J C Brown. J Clin Endocrinol Metab 1973
10
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.
. Diabetes Care 2020
. Diabetes Care 2020
10
The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor.
Meena Asmar, Ali Asmar, Lene Simonsen, Lærke Smidt Gasbjerg, Alexander Hovard Sparre-Ulrich, Mette Marie Rosenkilde, Bolette Hartmann, Flemming Dela, Jens Juul Holst, Jens Bülow. Diabetes 2017
Meena Asmar, Ali Asmar, Lene Simonsen, Lærke Smidt Gasbjerg, Alexander Hovard Sparre-Ulrich, Mette Marie Rosenkilde, Bolette Hartmann, Flemming Dela, Jens Juul Holst, Jens Bülow. Diabetes 2017
10
Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.
T B Usdin, E Mezey, D C Button, M J Brownstein, T I Bonner. Endocrinology 1993
T B Usdin, E Mezey, D C Button, M J Brownstein, T I Bonner. Endocrinology 1993
10
GIP and GLP-1: Stepsiblings Rather Than Monozygotic Twins Within the Incretin Family.
Michael A Nauck, Juris J Meier. Diabetes 2019
Michael A Nauck, Juris J Meier. Diabetes 2019
10
Chronic reduction of fasting glycemia with insulin glargine improves first- and second-phase insulin secretion in patients with type 2 diabetes.
Christian Pennartz, Nina Schenker, Björn A Menge, Wolfgang E Schmidt, Michael A Nauck, Juris J Meier. Diabetes Care 2011
Christian Pennartz, Nina Schenker, Björn A Menge, Wolfgang E Schmidt, Michael A Nauck, Juris J Meier. Diabetes Care 2011
10
Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
Geisa Nogueira Salles, Michele Longoni Calió, Christian Hölscher, Cristina Pacheco-Soares, Marimelia Porcionatto, Anderson Oliveira Lobo. Neuropharmacology 2020
Geisa Nogueira Salles, Michele Longoni Calió, Christian Hölscher, Cristina Pacheco-Soares, Marimelia Porcionatto, Anderson Oliveira Lobo. Neuropharmacology 2020
10
The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review.
David S Mathiesen, Jonatan I Bagger, Natasha C Bergmann, Asger Lund, Mikkel B Christensen, Tina Vilsbøll, Filip K Knop. Int J Mol Sci 2019
David S Mathiesen, Jonatan I Bagger, Natasha C Bergmann, Asger Lund, Mikkel B Christensen, Tina Vilsbøll, Filip K Knop. Int J Mol Sci 2019
10
GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release.
A H Sparre-Ulrich, M N Gabe, L S Gasbjerg, C B Christiansen, B Svendsen, B Hartmann, J J Holst, M M Rosenkilde. Biochem Pharmacol 2017
A H Sparre-Ulrich, M N Gabe, L S Gasbjerg, C B Christiansen, B Svendsen, B Hartmann, J J Holst, M M Rosenkilde. Biochem Pharmacol 2017
10
Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients.
V Pirags, H Lebovitz, P Fouqueray. Diabetes Obes Metab 2012
V Pirags, H Lebovitz, P Fouqueray. Diabetes Obes Metab 2012
10
Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes.
Francesca Cinti, Ryotaro Bouchi, Ja Young Kim-Muller, Yoshiaki Ohmura, P R Sandoval, Matilde Masini, Lorella Marselli, Mara Suleiman, Lloyd E Ratner, Piero Marchetti,[...]. J Clin Endocrinol Metab 2016
Francesca Cinti, Ryotaro Bouchi, Ja Young Kim-Muller, Yoshiaki Ohmura, P R Sandoval, Matilde Masini, Lorella Marselli, Mara Suleiman, Lloyd E Ratner, Piero Marchetti,[...]. J Clin Endocrinol Metab 2016
10
Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model.
Paul Richards, Helen E Parker, Alice E Adriaenssens, Joshua M Hodgson, Simon C Cork, Stefan Trapp, Fiona M Gribble, Frank Reimann. Diabetes 2014
Paul Richards, Helen E Parker, Alice E Adriaenssens, Joshua M Hodgson, Simon C Cork, Stefan Trapp, Fiona M Gribble, Frank Reimann. Diabetes 2014
10
Incretin hormones: Their role in health and disease.
Michael A Nauck, Juris J Meier. Diabetes Obes Metab 2018
Michael A Nauck, Juris J Meier. Diabetes Obes Metab 2018
10
Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial.
Megumi Inoue, Masanari Shiramoto, Tomonori Oura, Risa Nasu, Masako Nakano, Masakazu Takeuchi. Diabetes Ther 2019
Megumi Inoue, Masanari Shiramoto, Tomonori Oura, Risa Nasu, Masako Nakano, Masakazu Takeuchi. Diabetes Ther 2019
20
β-cell dedifferentiation in diabetes is important, but what is it?
Gordon C Weir, Cristina Aguayo-Mazzucato, Susan Bonner-Weir. Islets 2013
Gordon C Weir, Cristina Aguayo-Mazzucato, Susan Bonner-Weir. Islets 2013
10
The role of FOXO1 in β-cell failure and type 2 diabetes mellitus.
Tadahiro Kitamura. Nat Rev Endocrinol 2013
Tadahiro Kitamura. Nat Rev Endocrinol 2013
10
Sodium challenge does not support an acute gastrointestinal-renal natriuretic signaling axis in humans.
Richard A Preston, David Afshartous, Leonard R Forte, Rolando Rodco, Alberto B Alonso, Dyal Garg, Leopoldo Raij. Kidney Int 2012
Richard A Preston, David Afshartous, Leonard R Forte, Rolando Rodco, Alberto B Alonso, Dyal Garg, Leopoldo Raij. Kidney Int 2012
10
A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study.
Shizuka Kaneko, João D da Rocha Fernandes, Yuiko Yamamoto, Jakob Langer, Mads Faurby. Adv Ther 2021
Shizuka Kaneko, João D da Rocha Fernandes, Yuiko Yamamoto, Jakob Langer, Mads Faurby. Adv Ther 2021
33
A review of phenformin, metformin, and imeglimin.
Raghunandan Yendapally, Donald Sikazwe, Subin S Kim, Sushma Ramsinghani, Rheaclare Fraser-Spears, Amy P Witte, Brittany La-Viola. Drug Dev Res 2020
Raghunandan Yendapally, Donald Sikazwe, Subin S Kim, Sushma Ramsinghani, Rheaclare Fraser-Spears, Amy P Witte, Brittany La-Viola. Drug Dev Res 2020
10
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.